First Affiliated Hospital Of Fujian Medical University
Clinical trials sponsored by First Affiliated Hospital Of Fujian Medical University, explained in plain language.
-
New radioactive therapy shows promise for tough prostate cancer
Disease control OngoingThis early-phase trial tests a low dose of a radioactive drug called 225Ac-LNC1011 in 16 men with a type of advanced prostate cancer that has stopped responding to standard hormone therapy. The drug targets a protein (PSMA) on cancer cells to deliver radiation directly. The goal …
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New scans could sharpen bladder cancer diagnosis and treatment planning
Diagnosis OngoingThis study looks at whether newer PET/MRI scans (FAPI and FDG) are better than standard MRI at diagnosing muscle-invasive bladder cancer and predicting how well pre-surgery treatment works. About 80 participants will be scanned before and after therapy. The goal is to help doctor…
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated May 22, 2026 13:50 UTC
-
Blood test breakthrough could spot kidney cancer sooner
Diagnosis OngoingThis study looks at whether specific antibodies in the blood can help detect kidney cancer earlier and predict how the disease will progress. Researchers will analyze data from 400 patients to build a model that guides personalized treatment and avoids unnecessary risks. The goal…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated May 18, 2026 11:58 UTC
-
Researchers dig into medical records to crack the code of a rare brain disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks back at the medical records of 150 people diagnosed with Creutzfeldt-Jakob disease (CJD), a rare and fast-moving brain disorder. The goal is to spot common patterns in symptoms, lab tests, brain scans, and electrical brain activity. No new treatments or tests are…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 03:31 UTC
-
AI model could match kidney cancer patients to better treatments
Knowledge-focused OngoingThis study looks at 500 people with clear cell kidney cancer. Researchers will use CT scans and machine learning to predict levels of a protein called HIF-2α, which helps decide if a targeted drug (Belzutifan) might work. The goal is to match the right treatment to the right pati…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC